ZAIGHAM ABBAS RIZVI

Dr. ZAIGHAM ABBAS RIZVI

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2021 in Science Advances
Verified
Journal Article
Open access
ZRZAIGHAM ABBAS RIZVI
ZAIGHAM ABBAS RIZVI
RDRajdeep Dalal
Rajdeep Dalal
SSSrikanth Sadhu
Srikanth Sadhu
YKYashwant Kumar
Yashwant Kumar
SKShakti Kumar
Shakti Kumar
AAAmit Awasthi
Amit Awasthi
Salt triggers tumor immunity through microbiota-mediated NK cell activation.

11 January 2022 in eLife
Verified
Journal Article
Open access
ZRZAIGHAM ABBAS RIZVI
ZAIGHAM ABBAS RIZVI
RDRajdeep Dalal
Rajdeep Dalal
SSSrikanth Sadhu
Srikanth Sadhu
ABAkshay Anil Binayke
Akshay Anil Binayke
JDJyotsna Dandotiya
Jyotsna Dandotiya
AAAmit Awasthi
Amit Awasthi
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in the Golden Syrian hamster causes lung pathology that resembles human coronavirus disease (COVID-19). However, extrapulmonary pathologies associated with SARS-CoV-2 infection and post-COVID sequelae remain to be understood. Here, we show, using a hamster model, that the early phase of SARS-CoV-2 infection leads to an acute inflammatory response and lung pathologies, while the late phase of infection causes cardiovascular complications (CVCs) characterized by ventricular wall thickening associated with increased ventricular mass/body mass ratio and interstitial coronary fibrosis. Molecular profiling further substantiated our findings of CVC as SARS-CoV-2-infected hamsters showed elevated levels of serum cardiac troponin I, cholesterol, low-density lipoprotein, and long-chain fatty acid triglycerides. Serum metabolomics profiling of SARS-CoV-2-infected hamsters identified N-acetylneuraminate, a functional metabolite found to be associated with CVC, as a metabolic marker was found to be common between SARS-CoV-2-infected hamsters and COVID-19 patients. Together, we propose hamsters as a suitable animal model to study post-COVID sequelae associated with CVC, which could be extended to therapeutic interventions.

7 March 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
ZRZAIGHAM ABBAS RIZVI
ZAIGHAM ABBAS RIZVI
PBPrabhakar Babele
Prabhakar Babele
UMUpasna Madan
Upasna Madan
SSSrikanth Sadhu
Srikanth Sadhu
MTMANAS RANJAN TRIPATHY
MANAS RANJAN TRIPATHY
AAAmit Awasthi
Amit Awasthi
Cytokine release syndrome (CRS) due to severe acute respiratory coronavirus-2 (SARS-CoV-2) infection leads to life-threatening pneumonia which has been associated with coronavirus disease (COVID-19) pathologies. Centuries-old Asian traditional medicines such as Withania somnifera (L.) Dunal (WS) and Tinospora cordifolia (Willd.) Miers (TC) possess potent immunomodulatory effects and were used by the AYUSH ministry, in India during the COVID-19 pandemic. In the present study, we investigated WS and TC’s anti-viral and immunomodulatory efficacy at the human equivalent doses using suitable in vitro and in vivo models. While both WS and TC showed immuno-modulatory potential, WS showed robust protection against loss in body weight, viral load, and pulmonary pathology in the hamster model of SARS-CoV2. In vitro pretreatment of mice and human neutrophils with WS and TC had no adverse effect on PMA, calcium ionophore, and TRLM-induced ROS generation, phagocytosis, bactericidal activity, and NETs formation. Interestingly, WS significantly suppressed the pro-inflammatory cytokines-induced Th1, Th2, and Th17 differentiation. We also used hACE2 transgenic mice to further investigate the efficacy of WS against acute SARS-CoV2 infection. Prophylactic treatment of WS in the hACE2 mice model showed significant protection against body weight loss, inflammation, and the lung viral load. The results obtained indicate that WS promoted the immunosuppressive environment in the hamster and hACE2 transgenic mice models and limited the worsening of the disease by reducing inflammation, suggesting that WS might be useful against other acute viral infections. The present study thus provides pre-clinical efficacy data to demonstrate a robust protective effect of WS against COVID-19 through its broader immunomodulatory activity

13 September 2023 in Communications Biology
Verified
Journal Article
Open access
PDF file
ZRZAIGHAM ABBAS RIZVI
ZAIGHAM ABBAS RIZVI
JDJyotsna Dandotiya
Jyotsna Dandotiya
SSSrikanth Sadhu
Srikanth Sadhu
RKRitika Khatri
Ritika Khatri
JSJanmejay Singh
Janmejay Singh
AAAmit Awasthi
Amit Awasthi
A recently emerged sub-lineage of Omicron, BA.5, together with BA.4, caused a fifth wave of coronavirus disease (COVID-19) in South Africa and subsequently emerged as a predominant strain globally due to its high transmissibility. The lethality of BA.5 infection has not been studied in an acute hACE2 transgenic (hACE2.Tg) mouse model. Here, we investigated tissue-tropism and immuno-pathology induced by BA.5 infection in hACE2.Tg mice. Our data show that intranasal infection of BA.5 in hACE2.Tg mice resulted in attenuated pulmonary infection and pathology with diminished COVID-19-induced clinical and pathological manifestations. BA.5, similar to Omicron (B.1.1.529), infection led to attenuated production of inflammatory cytokines, anti-viral response and effector T cell response as compared to the ancestral strain of SARS-CoV-2, Wuhan-Hu-1. We show that mice recovered from B.1.1.529 infection showed robust protection against BA.5 infection associated with reduced lung viral load and pathology. Together, our data provide insights as to why BA.5 infection escapes previous SARS-CoV-2 exposure induced-T cell immunity but may result in milder immuno-pathology and alleviated chances of re-infectivity in Omicron-recovered individuals.

24 April 2024 in European Journal of Immunology
Verified
Journal Article
Closed access
ZRZAIGHAM ABBAS RIZVI
ZAIGHAM ABBAS RIZVI
SSSrikanth Sadhu
Srikanth Sadhu
JDJyotsna Dandotiya
Jyotsna Dandotiya
PSPuja Sharma
Puja Sharma
ABAkshay Binayke
Akshay Binayke
AAAmit Awasthi
Amit Awasthi

11 January 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
ZRZAIGHAM ABBAS RIZVI
ZAIGHAM ABBAS RIZVI
RDRajdeep Dalal
Rajdeep Dalal
SSSrikant Sadhu
Srikant Sadhu
YKYashwant Kumar
Yashwant Kumar
TSTripti Shrivastava
Tripti Shrivastava
AAAmit Awasthi
Amit Awasthi
Summary: Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 infection in golden Syrian hamster (GSH) causes lung pathology and resembles human coronavirus disease (Covid-19). However, extra-pulmonary pathologies of SARS-CoV-2 infection that result in long Covid remains undefined in GSH. Here, using in silico modelling we show that hamster angiotensin-converting enzyme-2 (ACE-2) and neuropilin-1 (NRP-1) interaction with SARS-CoV-2 is similar to human. Intranasal SARS-CoV-2 infection in GSH resulted in early onset of lung pathologies marked by aggressive inflammatory response. Remarkably, late phase of SARS-CoV2 infection in GSH showed cardiovascular complications (CVC) characterized by ventricular hypertrophy, ventricular wall thickening, interstitial coronary fibrosis and altered lipidomics with elevated cholesterol, low-density lipoprotein and long chain fatty acid triglycerides. Moreover, serum metabolomics profile of infected GSH correlated with Covid19 patients. Together, we propose GSH as a suitable animal model to study immediate and long Covid19 pathologies that could be extended to therapeutics against Covid19 related CVC.